TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
Recruiting · NCT06802081 · Registry updated 2026-01-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation | Arrhythmias, Cardiac, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 2 | 2026-01-13 | NCT06802081 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Cleveland Clinic | 239 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 558 |